Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Dillhoff

Showing results (181-190 of 199) with videos related to

Pageof 20
Sort By:
Annals of Surgical Oncology|December 16, 2019
Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database AnalysisKota Sahara, Diamantis I Tsilimigras, Rittal Mehta, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 1, 2018
Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancerMitchell L Ramsey, Erin Talbert, Daniel Ahn, et al.
International Journal of Molecular Sciences|August 29, 2024
Mature MUC5AC Expression in Resected Pancreatic Ductal Adenocarcinoma Predicts Treatment Response and OutcomesAshish Manne, Ashwini Esnakula, Ankur Sheel, et al.
Annals of Surgical Oncology|April 21, 2019
Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study GroupAlexandra G Lopez-Aguiar, Mohammad Y Zaidi, Eliza W Beal, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 7, 2019
Impact of perioperative blood transfusion on survival in pancreatic neuroendocrine tumor patients: analysis from the US Neuroendocrine Study GroupPaula Marincola Smith, Jordan Baechle, Carmen C Solórzano, et al.
Annals of Surgical Oncology|April 25, 2020
Specific Growth Rate as a Predictor of Survival in Pancreatic Neuroendocrine Tumors: A Multi-institutional Study from the United States Neuroendocrine Study GroupJordan J Baechle, Paula Marincola Smith, Marcus Tan, et al.
Annals of Surgical Oncology|April 29, 2020
Correction to: Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database AnalysisKota Sahara, Diamantis I Tsilimigras, Rittal Mehta, et al.
Neuroendocrinology|February 11, 2020
Long-Term Outcomes after Spleen-Preserving Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: Results from the US Neuroendocrine Study GroupKota Sahara, Diamantis I Tsilimigras, Amika Moro, et al.
Annals of Surgical Oncology|March 29, 2020
Impact of Insurance Status on Survival in Gastroenteropancreatic Neuroendocrine TumorsPaula Marincola Smith, Jordan Baechle, Marcus C Tan, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 30, 2016
Elevated NLR in gallbladder cancer and cholangiocarcinoma - making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy ConsortiumEliza W Beal, Lai Wei, Cecilia G Ethun, et al.
Pageof 20

Showing results (181-190 of 199) with videos related to

Sort By:
Pageof 20
Annals of Surgical Oncology|December 16, 2019
Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database AnalysisKota Sahara, Diamantis I Tsilimigras, Rittal Mehta, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 1, 2018
Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancerMitchell L Ramsey, Erin Talbert, Daniel Ahn, et al.
International Journal of Molecular Sciences|August 29, 2024
Mature MUC5AC Expression in Resected Pancreatic Ductal Adenocarcinoma Predicts Treatment Response and OutcomesAshish Manne, Ashwini Esnakula, Ankur Sheel, et al.
Annals of Surgical Oncology|April 21, 2019
Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study GroupAlexandra G Lopez-Aguiar, Mohammad Y Zaidi, Eliza W Beal, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 7, 2019
Impact of perioperative blood transfusion on survival in pancreatic neuroendocrine tumor patients: analysis from the US Neuroendocrine Study GroupPaula Marincola Smith, Jordan Baechle, Carmen C Solórzano, et al.
Annals of Surgical Oncology|April 25, 2020
Specific Growth Rate as a Predictor of Survival in Pancreatic Neuroendocrine Tumors: A Multi-institutional Study from the United States Neuroendocrine Study GroupJordan J Baechle, Paula Marincola Smith, Marcus Tan, et al.
Annals of Surgical Oncology|April 29, 2020
Correction to: Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database AnalysisKota Sahara, Diamantis I Tsilimigras, Rittal Mehta, et al.
Neuroendocrinology|February 11, 2020
Long-Term Outcomes after Spleen-Preserving Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: Results from the US Neuroendocrine Study GroupKota Sahara, Diamantis I Tsilimigras, Amika Moro, et al.
Annals of Surgical Oncology|March 29, 2020
Impact of Insurance Status on Survival in Gastroenteropancreatic Neuroendocrine TumorsPaula Marincola Smith, Jordan Baechle, Marcus C Tan, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 30, 2016
Elevated NLR in gallbladder cancer and cholangiocarcinoma - making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy ConsortiumEliza W Beal, Lai Wei, Cecilia G Ethun, et al.
Pageof 20